Posts Tagged ‘financial markets’

Novo Nordisk unveiled the results of a commercially risky study of CagriSema for obesity yesterday and it was another tough break for Novo Nordisk. The study aimed to prove that – at worst – this next generation combination obesity drug is as good as tirzepatide. There was a slim hope was that it might prove […]

This is a painful lesson and most of the world is very slow to take it to heart. Dealing with obesity – on almost every level – is a marathon, not a sprint. Today’s lesson is about orforglipron, an oral GLP-1 agonist in development by Lilly. This drug is a small molecule that can be […]

It’s hard to miss the headlines about wild gyrations in financial markets and tariff policies that have been coming in and out of view. We’re doing our best to stay out of those crosscurrents which threaten to become riptides. But the threat to place “a major tariff on pharmaceuticals” is hard to ignore, simply because […]

Oh my goodness. Wall Street is having waves of panic about the possibility that big food, big burrito, or big dialysis might not be able to keep selling us ever more of their services and stuff. For the last month we’ve been seeing ripples run through the stock market when investors started thinking maybe consumers […]